| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |